Gergely Róbert, Ecsedy Mónika, Kovács Illés, Papp András, Resch Miklós, Récsán Zsuzsa, Szabó Antal, Nagy Zoltán Zsolt
1 Semmelweis Egyetem, Általános Orvostudományi Kar, Szemészeti Klinika, Budapest, Üllői u. 26., 1085.
Orv Hetil. 2021 May 16;162(20):770-781. doi: 10.1556/650.2021.32062.
The aim of this study is to present our knowledge about pachychoroid diseases using case reports, literature review and our own clinical experiences. A summary flow chart of treatment options for the subgroups was prepared, too. Pachychoroid diseases include the following: central serous chorioretinopathy (CSCR), pachychoroid pigment epitheliopathy (PPE), pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy (PCV), peripapillary pachychoroid syndrome (PPS), focal choroidal excavation (FCE). A common feature of pachychoroid diseases is the quantitative or qualitative abnormality of the choroidea, which is often associated with subretinal fluid accumulation. The disease group does not currently have a standard treatment protocol; some of the multiple treatments prove to be more effective, however, there are significant differences between the subgroups. We summarize which subgroup benefits from eplerenone tablet therapy, micropulse laser therapy, verteporfin photodynamic therapy or intravitreal anti-VEGF injection therapy. Orv Hetil. 2020; 162(20): 770-781.
本研究旨在通过病例报告、文献综述及我们自己的临床经验,展示我们对厚脉络膜疾病的认识。还为各亚组准备了治疗方案的总结流程图。厚脉络膜疾病包括以下几种:中心性浆液性脉络膜视网膜病变(CSCR)、厚脉络膜色素上皮病变(PPE)、厚脉络膜新生血管病变(PNV)、息肉样脉络膜血管病变(PCV)、视乳头周围厚脉络膜综合征(PPS)、局限性脉络膜凹陷(FCE)。厚脉络膜疾病的一个共同特征是脉络膜存在定量或定性异常,常伴有视网膜下液积聚。该疾病组目前尚无标准治疗方案;多种治疗方法中的一些被证明更有效,然而,各亚组之间存在显著差异。我们总结了哪些亚组从依普利酮片治疗、微脉冲激光治疗、维替泊芬光动力治疗或玻璃体内抗VEGF注射治疗中获益。《匈牙利医学周报》。2020年;162(20):770 - 781。